Dotfix Tablet 1 mg is a novel uric acid-lowering agent used in the management of hyperuricemia associated with gout. It works by targeting specific pathways involved in uric acid metabolism to reduce serum uric acid levels.
Dotfix Tablet 1 mg is primarily used for the treatment of hyperuricemia in patients with gout. It helps in lowering elevated uric acid levels in the blood, thereby reducing the risk of gout attacks and managing chronic gout symptoms.
| Brand Name | Dotfix |
|---|---|
| Type | Tablet |
| Weight | 1 mg |
| Generic | Dotinurad |
| Manufacturer | Square Pharmaceuticals PLC |
| Available in | English বাংলা |
Dotfix Tablet 1 mg functions by inhibiting uric acid reabsorption in the kidneys. It acts on the urate transporter proteins in the renal tubules, thereby increasing the excretion of uric acid and lowering serum uric acid levels.
The onset of action for Dotfix Tablet 1 mg can vary, but significant reductions in serum uric acid levels are typically observed within a few weeks of starting treatment. Full therapeutic effects may take several weeks to achieve.
Dotfix Tablet 1 mg is absorbed from the gastrointestinal tract following oral administration. Peak plasma concentrations are generally reached within a few hours after ingestion.
Dotfix Tablet 1 mg is primarily excreted via the urine. A portion of the drug is metabolized in the liver before being eliminated through the kidneys.
The usual dosage of Dotfix Tablet 1 mg for adults is 40 mg once daily. Dosage adjustments may be necessary based on individual response and tolerability. It is important to follow the specific dosage recommendations provided by a healthcare provider.
Dotfix Tablet 1 mg is administered orally, typically in tablet form. It should be taken with or without food, as directed by a healthcare provider. The medication should be swallowed whole, and not crushed or chewed.
Common side effects of Dotfix Tablet 1 mg may include:
Toxicity associated with Dotfix Tablet 1 mg is uncommon but can occur with excessive doses. Symptoms of overdose may include severe gastrointestinal symptoms and potential electrolyte imbalances. In case of overdose, seek medical help immediately.
- Monitor kidney function regularly, as Dotfix Tablet 1 mg can affect renal function. - Use with caution in patients with a history of kidney disease or those on medications affecting renal function. - Adjust dosage in cases of severe renal impairment.
Dotfix Tablet 1 mg may interact with other medications, particularly those affecting renal function or uric acid metabolism. Always inform your healthcare provider of all medications you are taking, including over-the-counter drugs and supplements.
Patients with severe renal impairment or liver dysfunction may require dosage adjustments. Monitor for any adverse effects and consult with a healthcare provider to ensure safe use.
Dotfix Tablet 1 mg may interact with drugs that are also metabolized by the liver or those that affect kidney function. Potential interactions include:
There are no significant food interactions with Dotfix Tablet 1 mg. It can be taken with or without food. However, maintaining a balanced diet and adequate hydration is recommended to support overall health.
The safety of Dotfix Tablet 1 mg during pregnancy has not been well established. It should only be used during pregnancy if the potential benefits outweigh the risks. Consult with a healthcare provider for personalized advice.
The excretion of Dotfix Tablet 1 mg in breast milk is unknown. Caution is advised when using Dotfix Tablet 1 mg during lactation. Discuss with a healthcare provider to evaluate the risks and benefits.
In the event of an acute overdose, seek immediate medical attention. Symptoms may include severe gastrointestinal disturbances and potential electrolyte imbalances. Management involves supportive care and symptomatic treatment.
Dotfix Tablet 1 mg is contraindicated in individuals with known hypersensitivity to the drug or its components. It should be used cautiously in patients with severe renal impairment.
Follow the prescribed dosage and administration instructions provided by your healthcare provider. Do not exceed the recommended dose and inform your provider of any other medications or health conditions.
Store Dotfix Tablet 1 mg at room temperature, away from moisture and heat. Keep the medication out of reach of children and follow any specific storage instructions provided.
The volume of distribution of Dotfix Tablet 1 mg is not specifically well-defined, but it is distributed throughout the body tissues, primarily affecting the kidneys.
The half-life of Dotfix Tablet 1 mg is approximately 7 to 10 hours. This allows for once-daily dosing, but individual half-life may vary based on renal function and other factors.
Dotfix Tablet 1 mg is cleared predominantly through the kidneys. Clearance rates can be affected by renal function, requiring adjustments in patients with renal impairment.
See in details version Dotfix Tablet 1 mg also Dotfix Tablet 1 mg in bangla